AU511705B2 - Methylamine derivatives - Google Patents

Methylamine derivatives

Info

Publication number
AU511705B2
AU511705B2 AU25561/77A AU2556177A AU511705B2 AU 511705 B2 AU511705 B2 AU 511705B2 AU 25561/77 A AU25561/77 A AU 25561/77A AU 2556177 A AU2556177 A AU 2556177A AU 511705 B2 AU511705 B2 AU 511705B2
Authority
AU
Australia
Prior art keywords
methylamine derivatives
methylamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25561/77A
Other languages
English (en)
Other versions
AU2556177A (en
Inventor
Madeleine Broll
Pierre Eymard
Charles Pigerol
Jean-Claude Vernieres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Labaz SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz SA filed Critical Labaz SA
Publication of AU2556177A publication Critical patent/AU2556177A/en
Application granted granted Critical
Publication of AU511705B2 publication Critical patent/AU511705B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU25561/77A 1976-06-03 1977-05-27 Methylamine derivatives Ceased AU511705B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE842528 1976-06-03
BE842528 1976-06-03

Related Child Applications (2)

Application Number Title Priority Date Filing Date
AU53281/79A Division AU521822B2 (en) 1976-06-03 1979-11-28 Methyl amine derivatives
AU53280/79A Division AU528515B2 (en) 1976-06-03 1979-11-28 Methylamine derivatives

Publications (2)

Publication Number Publication Date
AU2556177A AU2556177A (en) 1978-11-30
AU511705B2 true AU511705B2 (en) 1980-09-04

Family

ID=3861370

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25561/77A Ceased AU511705B2 (en) 1976-06-03 1977-05-27 Methylamine derivatives

Country Status (17)

Country Link
JP (1) JPS6039261B2 (el)
AR (4) AR213646A1 (el)
AT (1) AT352088B (el)
AU (1) AU511705B2 (el)
DK (1) DK146063C (el)
ES (2) ES459466A1 (el)
FI (1) FI63015C (el)
FR (2) FR2374901A1 (el)
GR (1) GR61148B (el)
MX (1) MX4778E (el)
NL (1) NL7706052A (el)
NO (1) NO145337C (el)
NZ (1) NZ184161A (el)
PT (1) PT66623B (el)
SE (2) SE452317B (el)
YU (1) YU129577A (el)
ZA (1) ZA773151B (el)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES437790A1 (es) * 1974-05-20 1977-05-16 Labaz Procedimiento para preparar composiciones farmaceuticas y veterinarias.
BE842528R (fr) * 1976-06-03 1976-12-03 Derives actifs de methylamine, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions

Also Published As

Publication number Publication date
GR61148B (en) 1978-09-27
YU129577A (en) 1983-01-21
FI771780A (el) 1977-12-04
SE7706448L (sv) 1977-12-04
NO145337B (no) 1981-11-23
AU2556177A (en) 1978-11-30
NL7706052A (nl) 1977-12-06
DK146063B (da) 1983-06-20
AR215175A1 (es) 1979-09-14
FR2372795B1 (el) 1983-08-12
DK146063C (da) 1983-11-14
FR2374901A1 (fr) 1978-07-21
JPS52148006A (en) 1977-12-08
ES470379A1 (es) 1979-10-16
SE8206445D0 (sv) 1982-11-12
MX4778E (es) 1982-09-15
FI63015C (fi) 1983-04-11
FR2374901B1 (el) 1981-04-17
SE8206445L (sv) 1982-11-12
SE452763B (sv) 1987-12-14
AT352088B (de) 1979-08-27
AR215053A1 (es) 1979-08-31
FI63015B (fi) 1982-12-31
NO145337C (no) 1982-03-03
PT66623B (en) 1978-11-07
NZ184161A (en) 1980-10-08
NO771941L (no) 1977-12-06
SE452317B (sv) 1987-11-23
ZA773151B (en) 1978-04-26
ATA395877A (de) 1979-02-15
JPS6039261B2 (ja) 1985-09-05
DK244677A (da) 1977-12-04
ES459466A1 (es) 1978-08-16
AR213646A1 (es) 1979-02-28
FR2372795A1 (fr) 1978-06-30
AR215052A1 (es) 1979-08-31
PT66623A (en) 1977-07-01

Similar Documents

Publication Publication Date Title
AU519064B2 (en) 4-n-acylfortimicin b derivatives
AU509754B2 (en) Benazepine derivatives
AU517585B2 (en) Phenoxybenzyloxycarbonyl derivatives
AU507258B2 (en) Fluoroacacylresorcin derivatives
AU2610777A (en) Dipeptide derivatives
AU504526B2 (en) Pipeazine derivatives
AU517829B2 (en) Morphanthridine derivatives
AU502122B2 (en) 5-0-acylated-imidazole-4-carboxamide derivatives
AU515192B2 (en) Quinoxaline-din-oxide derivatives
AU510826B2 (en) Timing unit
AU512647B2 (en) Solpenamide derivatives
AU513069B2 (en) 17-spirosiltine derivatives
AU514803B2 (en) 4-phenylpipridine derivatives
AU507708B2 (en) Hydrazino-pyridazine derivatives
AU505150B2 (en) Triazolobenzazepine derivatives
AU528515B2 (en) Methylamine derivatives
AU511705B2 (en) Methylamine derivatives
AU503490B2 (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU519085B2 (en) 1-carba-2-penem derivatives
AU511948B2 (en) Nortropine-carbazate derivatives
AU1858676A (en) Aminoalkyl-dibenzocyclohepton-5-one derivatives
AU512688B2 (en) Thienyl-and T-aminophenyl-pyrrolidine derivatives
AU515135B2 (en) Ribofuranosyl-imidazole derivatives
AU540464B2 (en) Morphanthridine derivatives
AU508555B2 (en) 6-carboxy-flavone derivatives